交易 Celon Pharma SA - CLNP 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.150
• 长仓隔夜仓息调整: -0.02200%
• 短仓隔夜仓息调整: 0.00008%
• 隔夜调整仓息时间: 22:00 (UTC)
• 货币: PLN
• 最低成交量: 0.1
• 保证金: 20.00%
• 证券交易所: Poland
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 23.3
• 开仓: 23.35
• 1 年变化: 0.21%
• 日区间: 23.15 - 23.45

Celon Pharma S.A. (WSE: CLN) is an innovative Polish biopharmaceutical company focused on research, development, and production of proprietary therapies in oncology, psychiatry, and inflammatory diseases. With in-house R&D capabilities and a growing clinical pipeline, Celon aims to commercialize novel molecules for global markets. Its dual strategy of proprietary drug development and generic manufacturing ensures revenue diversification. The company offers investors exposure to high-potential biotech innovation anchored in local production and scientific expertise.